89 related articles for article (PubMed ID: 10824716)
1. Personality variables and compliance with insulin therapy in Type 2 diabetic subjects.
Gentili P; Maldonato A; Bloise D; Burla F; Coronel G; Di Paolantonio T
Diabetes Nutr Metab; 2000 Feb; 13(1):1-6. PubMed ID: 10824716
[TBL] [Abstract][Full Text] [Related]
2. [Attitudes toward insulin prescription in type 2 diabetic patients non-compliant with diet therapy].
Mordenti F; D'Angiolini G; Murgia F
Minerva Endocrinol; 2000; 25(3-4):61-7. PubMed ID: 11338397
[TBL] [Abstract][Full Text] [Related]
3. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
[TBL] [Abstract][Full Text] [Related]
4. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
5. The role of coping with disease in adherence to treatment regimen and disease control in type 1 and insulin treated type 2 diabetes mellitus.
Turan B; Osar Z; Molzan Turan J; Damci T; Ilkova H
Diabetes Metab; 2002 Jun; 28(3):186-93. PubMed ID: 12149598
[TBL] [Abstract][Full Text] [Related]
6. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
Bradley C; Gilbride CJ
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
[TBL] [Abstract][Full Text] [Related]
7. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
[TBL] [Abstract][Full Text] [Related]
8. Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs: a Korean study.
Noh JH; Park JK; Lee HJ; Kwon SK; Lee SH; Park JH; Ko KS; Rhee BD; Lim KH; Kim DJ
Diabetes Res Clin Pract; 2005 Sep; 69(3):243-8. PubMed ID: 16046024
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a new measure to evaluate psychological resistance to insulin treatment.
Petrak F; Stridde E; Leverkus F; Crispin AA; Forst T; Pfützner A
Diabetes Care; 2007 Sep; 30(9):2199-204. PubMed ID: 17575092
[TBL] [Abstract][Full Text] [Related]
10. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
[TBL] [Abstract][Full Text] [Related]
11. [Towards earlier nd more aggressive insulin therapy in type 2 diabetic patients].
Passa P
Diabetes Metab; 2001 Nov; 27(5 Pt 3):S5-6. PubMed ID: 11910978
[No Abstract] [Full Text] [Related]
12. Psychosocial barriers to starting insulin therapy in type 2 diabetes mellitus.
Hummel J; Kühner C; Kopf D; Krumm B; Deuschle M; Lederbogen F
Diabetes Res Clin Pract; 2008 Dec; 82(3):e25-6. PubMed ID: 18990464
[No Abstract] [Full Text] [Related]
13. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
[TBL] [Abstract][Full Text] [Related]
14. [Patient satisfaction in diabetes mellitus--measures and results].
Kohlmann T; Moock J
Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S120-3; discussion S124-6. PubMed ID: 18686221
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
16. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
Russell-Jones D; Khan R
Diabetes Obes Metab; 2007 Nov; 9(6):799-812. PubMed ID: 17924864
[TBL] [Abstract][Full Text] [Related]
17. [Perceived difficulties among primary care physicians for the prescription of insulin for diabetic patients].
Lenz Alcayaga R; Ramírez J; Gac R; Lorca E
Rev Med Chil; 2010 Mar; 138(3):281-8. PubMed ID: 20556329
[TBL] [Abstract][Full Text] [Related]
18. [Insulin therapy for elder diabetic patients].
Nagata M
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):452-4. PubMed ID: 11523145
[No Abstract] [Full Text] [Related]
19. Insulin therapy for type 2 diabetes.
Pergallo-Dittko V
Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
[No Abstract] [Full Text] [Related]
20. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
Rosendal H; Vondeling H; de Witte LP; Hutubessy RC; van Beekum WT; Heine RJ
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):166-71. PubMed ID: 11845567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
